Bayer Notches Dual EYLEA 8mg Wins With China nAMD Approval and EU 6-Month Interval Extension
High-dose aflibercept secured a regulatory victory in China as 6-month dosing nears European approval Good news apparently comes in twos…
The Potential for Better and Faster Drying with Longer Treatment Intervals
Sponsored by Bayer Experts share how aflibercept 8 mg could reshape clinical practice During the 16th Annual Congress on Controversies…
latest posts
